Delivery Order SPE2DB22D2218-SPE2DB25FR3HM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,670.02 to AmerisourceBergen Drug Corp for the supply of Victoza 3-Pak 18 mg/3 ml pen injections. This competitive award, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Victoza 3-Pak 18 mg/3 ml pen injections valued at $7,170.12 under a firm fixed price contract. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025, and represents a non-competitive, non-set-aside delivery order. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $3,128.38 to AmerisourceBergen Drug Corp for Victoza 3-Pak 18 mg/3 ml pen (3 ml) on September 22, 2025, with an ultimate completion date of September 23, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Victoza 3-Pak 18 mg/3 ml pen injections, with a ceiling value of $7,126.08. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract was completed on August 19, 2025, with performance to be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,386.73 to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Victoza 3-Pak 18 mg/3 ml pens with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order, which is not set-aside, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Victoza 3-Pak 18 mg/3 ml pen injections, with a contract ceiling value of $15,763.39. This competitively awarded, non-set-aside delivery order is classified as a firm fixed price contract and is scheduled for completion by September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Victoza 3-pak 18 mg/3 ml pen medications, valued at $1,729.72, with an award date of December 30, 2025 and ultimate completion date of December 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's broader pharmaceutical supply agreement. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $4,086.92 to AmerisourceBergen Drug Corp for the supply of Victoza 3-Pak 18 mg/3 ml pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 15, 2025. The award was issued on December 12, 2025, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Victoza is a prescription medication used in diabetes management, consistent with the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals. The $1,491.76 order is part of Amerisourcebergen's existing indefinite delivery contract to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. Amerisourcebergen Drug Corp, as the prime contractor, has a history of delivering a range...
- The Defense Logistics Agency awarded a delivery order valued at $1,187.70 to AmerisourceBergen Drug Corp for the supply of Victoza 3-Pak 18 mg/3 ml pen (3 ml), a diabetes medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and an ultimate completion date of August 25, 2025. The contract was executed on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR3HMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,096.87 to AmerisourceBergen Drug Corp for the supply of Victoza 3-Pak 18 mg/3 ml pen injections. This competitive award, issued on September 5, 2025, with a completion date of September 8, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee and will perform the work at its corporate office location. This delivery order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The Victoza delivery in this award supports the Defense Health Agency and other federal healthcare systems' diabetes treatment needs. All of AmerisourceBergen's reviewed contract awards have been competitively awarded and non-set-aside, reflecting the company's consistent ability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 9/5/25 |